ORIGINAL RESEARCH
Published on 17 Jul 2025
Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus
doi 10.3389/fendo.2025.1496671
- 2,120 views
- Frontiers in Endocrinology
- Clinical Diabetes
- Research Topics
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Pathogenesis, Prevention and Treatment
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Pathogenesis, Prevention and Treatment
10k
Total downloads
37k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 03 Jun 2025
Metabolite perturbations in type 1 diabetes associated with metabolic dysfunction-associated steatotic liver disease
doi 10.3389/fendo.2025.1500242
- 1,556 views
CASE REPORT
Published on 26 May 2025
Case Report: Amelioration of severe metabolic dysfunction-associated steatohepatitis after switching from conventional GLP-1RAs to tirzepatide
doi 10.3389/fendo.2025.1501984
- 2,100 views
ORIGINAL RESEARCH
Published on 17 Feb 2025
Impact of segmental body composition on metabolic dysfunction-associated fatty liver disease in Chinese children
doi 10.3389/fendo.2025.1505050
- 1,084 views
ORIGINAL RESEARCH
Published on 14 Jan 2025
The association between working hours and working type with non-alcoholic fatty liver disease: results from the NHANES 1999-2014
doi 10.3389/fendo.2024.1499735
- 1,657 views
ORIGINAL RESEARCH
Published on 13 Jan 2025
Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study
doi 10.3389/fendo.2024.1506953
- 1,069 views
- 2 citations
ORIGINAL RESEARCH
Published on 05 Dec 2024
Associations of serum folate and vitamin B12 levels with all-cause mortality among patients with metabolic dysfunction associated steatotic liver disease: a prospective cohort study
doi 10.3389/fendo.2024.1426103
- 2,603 views
ORIGINAL RESEARCH
Published on 21 Nov 2024
Development and pilot evaluation of an evidence-based algorithm for MASLD (formerly NAFLD) management in primary care in Europe
doi 10.3389/fmed.2024.1383112
- 1,572 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Sep 2024
Predicting cardiometabolic disease in medical students using FibroScan and 30-year Framingham risk scores
doi 10.3389/fmed.2024.1431935
- 3,230 views
ORIGINAL RESEARCH
Published on 25 Sep 2024
Identifying metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus using clinic-based prediction tools
doi 10.3389/fmed.2024.1425145
- 1,346 views
- 1 citation
ORIGINAL RESEARCH
Published on 19 Sep 2024
Associating plasma aldosterone concentration with the prevalence of MAFLD in hypertensive patients: insights from a large-scale cross-sectional study
doi 10.3389/fendo.2024.1451383
- 1,416 views
- 15 citations
REVIEW
Published on 23 May 2024
Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin
doi 10.3389/fendo.2024.1411706
- 3,450 views
- 6 citations
